Bill117th CongressFiled Nov 17, 2022Crime and Law Enforcement
S. 5123
Breakthrough Therapies Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Nov 17, 2022)
Breakthrough Therapies Act
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. It also provides for expedited controlled substance registrations through the Drug Enforcement Administration for researchers whose work involves investigational drugs.
What just happenedNov 17, 2022
Read twice and referred to the Committee on the Judiciary.
Who’s behind it
Sen. Booker, Cory A. [D-NJ](D-NJ)Sponsor
1 cosponsor1 R
1cosponsors1committees2actions
- Introduced in SenateNov 17, 2022
- Nov 17, 2022IntroReferral
Read twice and referred to the Committee on the Judiciary.
Judiciary Committee - Nov 17, 2022IntroReferral10000
Introduced in Senate